摘要
背景:糖尿病(DM)是一种严重的内分泌代谢性疾病,并伴有各种长期并发症。然而,已经确定了过多的目标,但可能会有不利的影响。因此,研究人员一直在寻找安全和更有效的治疗方法。天然产物,特别是来自植物,已被证明通过多种机制发挥抗糖尿病作用。 方法:综述糖尿病发病机制及其微血管并发症。提供了草药治疗糖尿病管理的可能潜在机制,突出了一些关键的治疗靶点。该综述还评价了草药产品通过调节炎症和肠道微生物群治疗糖尿病的最新进展。最后,我们讨论了目前可用的药物治疗方法。 结果:结果表明,许多植物已被证明是胰岛素分泌剂、α-葡萄糖苷酶和α-淀粉酶抑制剂的良好来源。在非常规靶点中,抑制脂肪酶、胆碱酯酶和血管紧张素转换酶等关键酶已直接和/或间接地与糖尿病和糖尿病并发症有关。例如,从穿孔金丝桃中分离的金丝霉素、假金丝霉素和I3、ii8-双芹菜素,以及从金金丝桃中分离的棕榈和钴胺。W.T.Wang&P.K分别被发现是强大的脂肪酶和胆碱酯酶抑制剂。此外,据报道,许多植物衍生化合物如玉米麸、黄芩素和小檗碱的铁酰化低聚糖通过调节肠道微生物群介导抗糖尿病特性。 结论:本综述中积累的信息有望为支持天然抗糖尿病药物开发的先进研究提供有用的科学基线信息。
关键词: 糖尿病,微生物组,脂肪酶,胆碱酯酶,血管紧张素转换酶,药物。
Current Medicinal Chemistry
Title:Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Volume: 28 Issue: 23
关键词: 糖尿病,微生物组,脂肪酶,胆碱酯酶,血管紧张素转换酶,药物。
摘要:
Background: Diabetes Mellitus (DM) is a severe endocrine metabolic disease coupled with various long-term complications. A plethora of targets have been identified, however, with possible adverse effects. Therefore, researchers are in the perpetual quest for safe and more effective therapeutics. Natural products, particularly derived from plants, have proven to exert anti-diabetic effects via diverse mechanisms.
Methods: An overview of DM pathogenesis and its associated micro- and macro-vascular complications is presented. Possible underlying mechanisms of herbal remedies in DM management are provided, highlighting some key therapeutic targets. The review also appraises the recent progress of herbal products in treating DM through regulating inflammation and gut microbiota. Finally, currently available pharmacological treatments are discussed.
Results: The results show that numerous plants have proven to be promising sources of insulin secreting agents, α-glucosidase and α-amylase inhibitors. Among the non- conventional targets, inhibition of key enzymes such as lipase, cholinesterases and angiotensin converting enzyme has been directly and/or indirectly linked to DM and DM complications. For instance, hypericin, pseudohypericin and I3,II8-biapigenin isolated from Hypericum perforatum L., and palmatine and columbamine isolated from Dichocarpum auriculatum (Franch.) W. T. Wang & P. K have been found to be powerful lipase and cholinesterase inhibitors, respectively. Moreover, a number of plant-derived compounds such as feruloylated oligosaccharides from maize bran, baicalein and berberine are reported to mediate anti-diabetic property via modulation of gut microbiota.
Conclusion: The information amassed in this review is anticipated to provide useful scientific baseline information to support advanced research in natural antidiabetic drug development.
Export Options
About this article
Cite this article as:
Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867327666201102120120
DOI https://dx.doi.org/10.2174/0929867327666201102120120 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Coronary CT Angiography in the Diagnosis of Coronary Artery Disease
Current Medical Imaging ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design The Role of Orexin System in Antipsychotics Induced Weight Gain
Current Psychiatry Reviews Pre-Clinical and Clinical Evaluation of Nuclear Tracers for the Molecular Imaging of Vulnerable Atherosclerosis: An Overview
Current Medicinal Chemistry Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Polyphenols and Cardiovascular Disease: A Critical Summary of the Evidence
Mini-Reviews in Medicinal Chemistry Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science Models and Methods in Cardiac Imaging for Metabolism Studies
Current Pharmaceutical Design Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Herb-Drug Interactions: An Insight into Cardiovascular Diseases Based on Case Reports
Cardiovascular & Hematological Agents in Medicinal Chemistry Familial Hypercholesterolemia: Update and Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic:Translating Clinical Evidence into the Practice of Diabetes Care (Guest Editor: Richard W. Grant Contents)]
Current Diabetes Reviews Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
Current Neuropharmacology Editorial [(Poly)phenol Chemistry: Part II - Physicochemical Properties & Biological Implications (Guest Editor: Stefan Chassaing)]
Current Organic Chemistry Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation
Current Pharmacogenomics and Personalized Medicine Chagas Heart Disease Pathogenesis: One Mechanism or Many?
Current Molecular Medicine Editorial [Hot topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Smoking-Related Cardiovascular Diseases (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers
Current Drug Safety Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca<sup>2+</sup> Release Channel: Case Study of Dantrolene
Current Pharmaceutical Design